Governance
Ecraid is a not-for-profit foundation that employs a Management Board, a central operational service, and central support staff at our headquarters in Utrecht, the Netherlands.
The Management Board is responsible for the overall coordination and management of Ecraid and is supervised by a Supervisory Board.
Ecraid's Coordinating Committee is tasked with strategic guidance and important decisions. It comprises some of Europe's leading experts in infectious diseases.
Scientific guidance is provided by our Scientific Advisory Board.
Coordinating Committee
The Ecraid Coordinating Committee functions as the central body within Ecraid and is responsible for the European-wide coordination of clinical studies on infectious diseases, strategy development, stakeholder management, and service and network development.
Marc Bonten
Chair, Ecraid Chief Executive Officer
CLIN-Net
Evelina Tacconelli
Chief Scientific Officer Ecraid
EPI-Net, LOTTA-Net, ORCHESTRA
Sibyl Anthierens
Public engagement
Roger Brüggemann
Pharmacology, pharmaceutical support, Pharmacometrics (P3) network
Christopher Butler
ECRAID-Prime, POS-ARI-PC, PRUDENCE
Oliver Cornely
VACCELERATE
Jacques Demotes-Mainard
ECRIN, Data management
Lennie Derde
REMAP-CAP
Bruno François
POS-VAP
Carlo Giaquinto
PENTA-ID, VERDI
Stephan Harbarth
STAT-Net
Peter Horby
POS-ARI-ER, MERMAIDS 2.0
Thomas Jaenisch
RECODID, Data sharing
Marion Koopmans
Outbreak preparedness and response, POS-Disease X, VEO
Surbhi Malhotra
LAB-Net
Pontus Naucler
Vice chair Ecraid Clinical Liaison Council
Jesús Rodriguez Baño
POS-cUTI
Oana Săndulescu
Chair Ecraid Clinical Liaison Council
Arjana Tambić Andrašević
Capacity building, Eastern Europe
Yazdan Yazdanpanah
EU-RESPONSE
Scientific Advisory Board
Ecraid's Scientific Advisory Board provides the Coordinating Committee with expert advice and feedback on its services, network composition, innovative trial designs and technologies, as well as ethics, among others.
Evelina Tacconelli
Chair, Chief Scientific Officer Ecraid
University of Verona
Frank Møller Aarestrup
Technical University of Denmark
Antonino Di Caro
Unicamillus International University of Medicine Rome
Xavier De Lamballerie
Aix Marseille University
Vance Fowler
Duke University, Antibiotic Resistance Leadership Group
Nina Gobat
University of Oxford
Nicole Lurie
Coalition for Epidemic Preparedness Innovations
Marc Mendelson
University of Cape Town
Seamus O’Brien
Global Antibiotic Research and Development Partnership
David Paterson
University of Queensland
ADVANCE-ID
Hervé Raoul
INSERM
Guy Thwaites
Clinical Research Unit, University of Oxford
Robert Weinstein
Rush University, Chicago
Marco Cavaleri
Observer to the Scientific Advisory Board
European Medicines Agency
Supervisory Board
The Supervisory Board ensures that the Management Board manages the foundation in accordance with the mission, identity, and objectives of Ecraid and that it acts and performs adequately. The Supervisory Board consists of global scientific experts and representatives of leading European and international scientific projects, networks, and organisations with activities complementary to Ecraid's.
Arno Hoes
Chair
Executive Board member and Dean at UMC Utrecht, the Netherlands
Annie van Broekhoven
Managing Director, CreaBioSupport BVBA, Belgium
Deborah Cook
Academic Chair of Critical Care, McMaster University, Canada
Juan Emilio Echevarría
Laboratory Head, Instituto de Salud Carlos III, Spain
Bernard Pécoul
Former Executive Director Drugs for Neglected Diseases initiative, Switzerland
Momir Radulović
Observer to the Supervisory Board
Board member European Medicines Agency, Executive Director Slovenian Medicines Agency, Slovenia